Here, we demonstrated that the postbiotic Tyra, the metabolite of Lactobacillus paracasei, could efficiently upregulate surface MHC-I expression and augment the efficacy of immunotherapy in HR+/HER2– breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.